The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Bosley Katrine since 2017.
The trader's CIK number is 1592469.
At the time of the last reporting, Bosley Katrine was the President and CEO of Editas Medicine, Inc.. (stock ticker symbol EDIT).
Also see all insider trading activities at Editas Medicine, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | EDIT | 0 | $0 | 12,000 | $303,240 | 0 | $0 |
| 2018 | EDIT | 0 | $0 | 165,798 | $5,651,541 | 0 | $0 |
| 2017 | EDIT | 0 | $0 | 58,331 | $1,332,650 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-01-08 | EDIT | Sale | 12,000 | 25.27 | 303,240 |
| 2018-12-03 | EDIT | Sale | 12,000 | 32.16 | 385,860 |
| 2018-11-01 | EDIT | Sale | 12,000 | 26.62 | 319,440 |
| 2018-10-01 | EDIT | Sale | 12,000 | 31.04 | 372,480 |
| 2018-09-04 | EDIT | Sale | 12,000 | 32.67 | 392,040 |
| 2018-08-20 | EDIT | Sale | 12,000 | 30.19 | 362,280 |
| 2018-08-01 | EDIT | Sale | 8,333 | 29.74 | 247,823 |
| 2018-07-02 | EDIT | Sale | 8,333 | 36.23 | 301,904 |
| 2018-06-01 | EDIT | Sale | 8,333 | 38.52 | 321,028 |
| 2018-05-01 | EDIT | Sale | 8,333 | 31.95 | 266,239 |
| 2018-04-02 | EDIT | Sale | 8,333 | 32.22 | 268,489 |
| 2018-03-09 | EDIT | Sale | 9,134 | 45.00 | 411,030 |
| 2018-03-01 | EDIT | Sale | 8,333 | 35.63 | 296,904 |
| 2018-02-01 | EDIT | Sale | 8,333 | 36.70 | 305,837 |
| 2018-01-29 | EDIT | Sale | 10,000 | 37.53 | 375,340 |
| 2018-01-30 | EDIT | Sale | 10,000 | 40.05 | 400,520 |
| 2018-01-23 | EDIT | Sale | 3,338 | 35.28 | 117,764 |
| 2018-01-02 | EDIT | Sale | 8,333 | 32.78 | 273,147 |
| 2018-01-03 | EDIT | Sale | 6,662 | 35.04 | 233,416 |
| 2017-12-01 | EDIT | Sale | 8,333 | 29.50 | 245,790 |
| 2017-11-01 | EDIT | Sale | 8,333 | 24.22 | 201,858 |
| 2017-10-02 | EDIT | Sale | 8,333 | 25.05 | 208,741 |
| 2017-09-01 | EDIT | Sale | 10,000 | 20.80 | 207,970 |
| 2017-09-05 | EDIT | Sale | 6,666 | 20.20 | 134,679 |
| 2017-08-10 | EDIT | Sale | 10,000 | 20.02 | 200,159 |
| 2017-08-11 | EDIT | Sale | 6,666 | 20.02 | 133,453 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bosley Katrine (President and CEO of Editas Medicine, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.